It has been suggested, but not yet proven, that intermittent fasting improves liver health independent of weight loss/caloric restriction because it changes the way the body utilizes energy and favours the metabolism of fat thus theoretically acting to improve the bodys ability to breakdown excess stored liver fat that is characteristic of NAFLD

The company claims its semaglutide drops, which are applied under the tongue, contain the same active ingredient found in Ozempic and Wegovy and provide the powerful benefits of GLP-1 without injections. EllieMD further touts, under a benefits tab on the drops product page, that the drops offer prescription appetite suppression and are scientifically backed to help users lose weight, adding that the drops can help to lower blood sugar levels and potentially reduce the risk factors associated with conditions like type 2 diabetes, high blood pressure and cardiovascular disease, which are often linked to diabetes. Meanwhile, a recent EllieMD Instagram post boasts about the cardiovascular benefits of its GLP-1 medication, including decreased risk of cardiovascular disease, heart attack and stroke
Find out our article about red and near infrared light therapy
Current guidelines do not recommend combination therapy with GLP-1 RAs and DPP-4 inhibitors, and the ADA/EASD consensus report specifically recommends discontinuation of DPP-4 inhibitors when initiating GLP-1 RA therapy
Methods: UC was induced in BALB/c mice with 3% DSS for 14 days